Quantcast
Last updated on April 18, 2014 at 11:57 EDT

Latest Prodrugs Stories

2013-08-07 12:27:36

MUMBAI and BALTIMORE, August 7, 2013 /PRNewswire/ -- Announces Acquisition of Exclusive US Rights to Alinia(R) for Oral Suspension Pharmaceutical Major, Lupin Ltd. and its US subsidiary, Lupin Pharmaceuticals Inc. (collectively Lupin) announced today that it has signed a strategic licensing agreement with US pharmaceutical company Romark Laboratories, L.C. (Romark) which grants Lupin exclusive rights to promote, distribute and market Alinia(R) (nitazoxanide) for Oral...

2013-08-07 12:26:28

Lupin Acquires Exclusive License to Promote and Distribute Alinia for Oral Suspension in the United States using its Pediatric-Focused Sales Force TAMPA, Fla., Aug. 7, 2013 /PRNewswire/ -- Romark Laboratories announced that it has entered into a strategic agreement with Lupin Limited and its subsidiaries (collectively Lupin) designed to expand promotion and distribution efforts related to its Alinia(®) (nitazoxanide) for Oral Suspension, 100 mg/5 mL. Under the agreement, Lupin...

2013-07-26 18:38:55

Study finds that high platelet reactivity on clopidogrel predicts stent thrombosis, heart attack, and bleeding but is not directly linked to death Patients who receive a drug-eluting stent (DES) and demonstrate high platelet reactivity on clopidogrel are more likely to have blood clots form on the stent and to suffer a heart attack; however, these patients are less likely to develop bleeding complications. One-year results of the ADAPT-DES trial will be published online July 26, 2013, in...

2013-07-24 23:25:20

Passages Malibu urges awareness of the growing trend of heroin abuse among illicit drug culture. Malibu, CA (PRWEB) July 24, 2013 Over the past weeks and months, analysis and careful monitoring of emerging developments in the subculture of illegal substances has revealed a troubling, but difficult to ignore trend. Long a fading ember in the drug world, heroin has found new energy as the substance of choice among far too many people, across multiple states in the US, and in steadily...

2013-07-18 12:28:01

WOODCLIFF LAKE, N.J., July 18, 2013 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for fenofibric acid EQ 45 mg and EQ 135 mg delayed-release (DR) capsules. Fenofibric acid DR is the generic version of AbbVie's Trilipix(®) and is indicated: in combination with a statin to reduce TG and increase HDL-C in patients with mixed dyslipidemia and CHD...

2013-07-15 12:25:18

PITTSBURGH, July 15, 2013 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched Fenofibric Acid Delayed-release Capsules, 45 mg and 135 mg. Fenofibric Acid Delayed-release Capsules, 45 mg and 135 mg, are the generic version of Abbott's Trilipix® Capsules, which are indicated as an adjunct to diet in combination with a statin to reduce triglyceride and increase high-density lipoprotein cholesterol in...

2013-07-01 11:26:29

Elevated HOXB13/IL17BR ratio may indicate who should receive extended treatment with letrozole A biomarker reflecting expression levels of two genes in tumor tissue may be able to predict which women treated for estrogen-receptor (ER)-positive breast cancer should receive a second estrogen-blocking medication after completing tamoxifen treatment. In their report being published online in the Journal of the National Cancer Institute, Massachusetts General Hospital (MGH) Cancer Center...

2013-06-24 16:27:25

Join the call to hear from legal, policy experts about the decision's impact on drug safety WASHINGTON, June 24, 2013 /PRNewswire-USNewswire/ -- The following is being released by the American Association for Justice: Today the U.S. Supreme Court issued another handout to the generic drug industry, shielding it from lawsuits for the design of their drugs at the cost of consumer safety. In a 5-4 decision in Mutual Pharmaceutical Co. v. Bartlett the Court, once again, let a generic...

2013-06-21 12:49:39

One of the largest clinical trials done in infants with congenital (present at birth) heart diseases, published in the New England Journal of Medicine, shows that the increasingly common practice of using the drug clopidogrel (Plavix®) to reduce shunt-related blood flow issues is not effective in the dose studied. “Once again, pediatric-specific research shows that newborns and infants are not little adults," said David Wessel, MD, Chief Medical Officer, Children's National Medical...

2013-06-18 09:48:37

A missing brain enzyme increases concentrations of a protein related to pain-killer addiction, according to an animal study. The results will be presented Monday at The Endocrine Society's 95th Annual Meeting in San Francisco. Opioids are pain-killing drugs, derived from the opium plant, which block signals of pain between nerves in the body. They are manufactured in prescription medications like morphine and codeine, and also are found in some illegal drugs, like heroin. Both legal and...